Amedisys: Q3 Earnings Insights


Amedisys AMED reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


Amedisys missed estimated earnings by 5.74%, reporting an EPS of $1.15 versus an estimate of $1.22.

Revenue was up $4.50 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.24 which was followed by a 4.81% drop in the share price the next day.

Here's a look at Amedisys's past performance:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 1.23 1.12 1.18 1.36
EPS Actual 1.47 1.23 1.18 1.53
Revenue Estimate 583.12M 558.84M 555.20M 568.37M
Revenue Actual 557.89M 545.26M 559.32M 553.49M

To track all earnings releases for Amedisys visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!